Frank H. Laukien - 06 Jun 2025 Form 4 Insider Report for BRUKER CORP (BRKR)

Role: PRESIDENT & CEO, Director, 10%+ Owner
Signature: /s/ Michael A Simone, Attorney-in-Fact
Issuer symbol: BRKR
Transactions as of: 06 Jun 2025
Net transactions value: +$100,043
Form type: 4
Filing time: 09 Jun 2025, 16:15:11 UTC
Previous filing: 19 Feb 2025
Next filing: 07 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
LAUKIEN FRANK H	PRESIDENT & CEO, Director, 10%+ Owner	C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA	/s/ Michael A Simone, Attorney-in-Fact	09 Jun 2025	0001133649

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BRKR	Common Stock	Purchase	$100,043	+2,608	+0.01%	$38.36	38,462,171	06 Jun 2025	Direct	F1
holding	BRKR	Common Stock						1,046,499	06 Jun 2025	By Former Spouse
holding	BRKR	Common Stock						337,087	06 Jun 2025	By Son
holding	BRKR	Common Stock						336,607	06 Jun 2025	By Daughter
holding	BRKR	Common Stock						201,702	06 Jun 2025	As UTMA Custodian for Son
holding	BRKR	Common Stock						71,728	06 Jun 2025	As UTMA Custodian for Son
holding	BRKR	Common Stock						492	06 Jun 2025	By Former Spouse
holding	BRKR	Common Stock						272	06 Jun 2025	By Son

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.27 to $38.47, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.27 to $38.47, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.